Avanzanite Italy Launch Sales Trigger

🚀 Battle Card: Avanzanite Bioscience B.V.

• Giovanni Galliano, General Manager, Italy · 🔗 [LinkedIn](https://www.linkedin.com/in/giovanni-galliano-687b2113/)

• Italy is now the EU’s third-largest rare disease market; local leadership will define orphan drug access speed. → Source

• Building a Milan-based commercial team from scratch

• Engaging the thalassemia & rare disease community for access

• Primary: Specialty pharma launch team augmentation → rapidly scale Italian operations and secure market access

• Expansion: Digital patient engagement & stakeholder management platform → strengthen ties with patient associations and payers

• HQ: Amsterdam, NL

• Employees: ≈ 60

• Rev: ≈ $50 M

• Website: [avanzanite.com](https://www.avanzanite.com)

🤼 Competitive Intel

• Veeva Systems — CRM / Commercial Cloud
• Unique edge: Industry-standard life sciences CRM
• Evaluated by VP Commercial for global roll-out fit

• IQVIA — Analytics / Data Services
• Unique edge: Deep patient and market analytics
• Evaluated by Head of Market Access for real-time insights

• Syneos Health — Commercialization Services
• Unique edge: End-to-end launch capabilities
• Evaluated by COO for operational scalability

• Parexel — Market Access & HEOR
• Unique edge: Health economics expertise
• Evaluated by Director of Reimbursement for pricing strategy

• Ashfield — Patient Engagement
• Unique edge: On-the-ground rare disease community programs
• Evaluated by Head of Medical Affairs for local network

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑❑
OFFER_BRIEF   = ❑Rapidly scale Italian commercial operations for orphan drug launches❑
PROOF_METRIC  = ❑Revenue tripled YoY❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Giovanni
COMPANY     = Avanzanite Bioscience B.V.
DEPT        = Operations
SIZE        = ≈0
BOTTLENECK  = Building the local team from scratch slows growth
EVENT       = General Manager Appointment
DETAIL      = Italian operations expansion
PAIN        = Slower orphan drug launches without a local team
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20251013986565&div=41152219
SIM_CO      = Genzyme
WIN_METRIC  = 3x Q3 revenue YoY
NEXT_SIZE   = ≈10
EMP_EST     = ≈60
REV_EST     = ≈$50M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈0-person Operations

Giovanni—noticed your Operations team is ≈0.

That’s when Building the local team from scratch slows growth.

We helped Genzyme fix this with Rapidly scale Italian commercial operations for orphan drug launches.

Result: 3x Q3 revenue YoY.  
Quick call?

PS—next bottleneck hits ≈10.

DM ≤45 words, TONE:
Saw your post about Italian operations expansion — Slower orphan drug launches without a local team.  
Rapidly scale Italian commercial operations for orphan drug launches. Revenue tripled YoY. Quick chat?